Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peripheral blood flow is the movement of blood through the peripheral vasculature (arteries, capillaries, and veins) supplying tissues outside the central circulatory organs. It is regulated by vessel diameter (vasoconstriction/vasodilation), neural and hormonal signals, and is crucial for tissue oxygenation and nutrient delivery. Abnormal peripheral blood flow underlies multiple disorders, such as peripheral artery disease and vascular complications in shock and hypertension. Therapeutic drugs may alter peripheral blood flow indirectly through action on molecular targets like adrenergic receptors or enzymes regulating vascular tone.
Vasodilation (drug-induced widening of blood vessels); Vasoconstriction (drug-induced narrowing of blood vessels); Endothelial modulation (e.g., via nitric oxide, endothelin)
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peripheral blood flow.